| Dr Paraclet Louissaint, MD | |
|
669 Elizabeth Ave, Newark, NJ 07112-2342 | |
| (973) 923-6452 | |
| (973) 923-1979 |
| Full Name | Dr Paraclet Louissaint |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 669 Elizabeth Ave, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164519179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | MA045798 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paraclet Louissaint, MD 669 Elizabeth Ave, Newark, NJ 07112-2342 Ph: (973) 923-6452 | Dr Paraclet Louissaint, MD 669 Elizabeth Ave, Newark, NJ 07112-2342 Ph: (973) 923-6452 |
News Archive
Repeating the message of so many years, World AIDS Day has come and gone. This year, the focus was on improving communication between the "victims" and the healthcare providers so that the former can get the care they need without having to come to terms with their lifestyle choices.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 infection.
24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-na-ve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) and Ribavirin (RBV), according to new research presented today at the International Liver Congress 2010, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced that Israeli soldiers who suffer severe traumatic brain injury (TBI) can be enrolled in the company's Phase II-b STOP-TBI trials at clinical sites in Israel.
The Canadian Institute of Health Research has awarded $929,475 to Professor Jo Knight of Lancaster Medical School, Lancaster Data Science Institute and the Department of Psychiatry at the University of Toronto.
› Verified 6 days ago
Dr. Consolata Uzzi, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 174 Hillside Ave, Newark, NJ 07108 Phone: 201-667-4000 | |
Katie Marie Sanghvi, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 150 Bergen St., The University Hospital, Newark, NJ 07103 Phone: 973-972-4300 Fax: 513-831-5985 | |
Dr. Sheila R Rugnao, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 185 S Orange Ave # G506, Newark, NJ 07103 Phone: 415-624-5306 | |
Dr. Cynthia Darlene Santos, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-972-9438 | |
Scarlett Finocchiaro, General Practice Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7000 |